RAG8 peptide

• UNSPSC Description:

  RAG8 peptide is an antagonist for protease-activated receptor 4 (PAR 4), which inhibits late-stage platelet activation, and reduces thrombosis without altering hemostasis or increasing bleeding risk. RAG8 peptide can be used for atherosclerosis research[1].

• Target Antigen:

  Protease Activated Receptor (PAR)

• Type:

  Peptides

• Related Pathways:

  GPCR/G Protein

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/rag8-peptide.html

• Smiles:

  CCCCCCCCCCCCCCCC(N[C@@H](CCCNC(N)=N)C(N[C@@H](C)C(NCC(N[C@@H](CC(C)C)C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CO)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O

• Molecular Weight:

  1171.48

• References & Citations:

  [1]Barrett TJ. Targeting PAR4 to Reduce Atherosclerosis. Arterioscler Thromb Vasc Biol. 2023 Nov;43(11):2179-2182.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported